Compositions and methods for non-targeted activation of endogenous genes
US7419828B2 · kind B2 · utility
Assignee
Inventor
Key dates
| Filing date | Jan 18, 2000 |
| Grant date | Sep 2, 2008 |
| Priority date | — |
| Expiry date | Apr 3, 2023 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2840/44
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed generally to activating gene expression or causing over-expression of a gene by recombination methods in situ. The invention also is directed generally to methods for expressing an endogenous gene in a cell at levels higher than those normally found in the cell. In one embodiment of the invention, expression of an endogenous gene is activated or increased following integration into the cell, by non-homologous or illegitimate recombination, of a regulatory sequence that activates expression of the gene. The invention also provides methods for the identification, activation, isolation, and/or expression of genes undiscoverable by current methods since no target sequence is necessary for integration. The invention is specifically directed to methods of drug discovery using the activated gene products for compound testing.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.